This study, called The Indiana Myeloma Registry, is collecting information and samples from people with plasma cell dyscrasias (a group of conditions affecting certain blood cells). This includes conditions like Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, Multiple Myeloma, and Plasmacytoma. The goal is to create a collection of data and biological samples over five years to help with future research. This is an observational study, meaning you won't receive any new treatments; researchers will simply gather information. You may be able to join if you are 18 years or older and have been diagnosed with or are suspected to have one of these conditions. The study aims to enroll 2500 participants.

Study design

This is an observational study that plans to include 2500 participants. It is not testing a specific drug or intervention.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary goal is to create a repository, measured at 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.